Literature DB >> 8996422

A new syndrome of liver iron overload with normal transferrin saturation.

R Moirand1, A M Mortaji, O Loréal, F Paillard, P Brissot, Y Deugnier.   

Abstract

BACKGROUND: We investigated patients who had unexplained hepatic iron overload and normal transferrin saturation.
METHODS: 65 patients with a median liver iron concentration of 65 mumol/g dry weight of liver (normal < 36 mumol/g), hyperferritinaemia (566 micrograms/L; normal < 400 micrograms/L), and normal transferrin saturations (32%) were compared with genetic haemochromatosis (GH) controls including homozygous (matched for sex and serum ferritin concentration) and heterozygous individuals. Relatives of patients who had ratios of liver iron concentration to age greater than 1.9 were also studied.
FINDINGS: The 65 patients were significantly older and had significantly less hepatic iron overload than individuals with genetic haemochromatosis. The frequency of HLA-A3 antigen was significantly lower in these patients than in individuals with homozygous (p < 0.0001) or heterozygous (p < 0.0002) GH. Five HLA-identical siblings of the patients had normal serum ferritin concentrations. Most of the patients (95%) had one or more of the following conditions; obesity, hyperlipidaemia, abnormal glucose metabolism, or hypertension.
INTERPRETATION: We have found a new non-HLA-linked iron-overload syndrome which suggests a link between iron excess and metabolic disorders. The current diagnostic criteria for genetic haemochromatosis should be reviewed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8996422     DOI: 10.1016/S0140-6736(96)06034-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  51 in total

Review 1.  Magnetic resonance imaging quantification of liver iron.

Authors:  Claude B Sirlin; Scott B Reeder
Journal:  Magn Reson Imaging Clin N Am       Date:  2010-08       Impact factor: 2.266

2.  Variable phenotypic presentation of iron overload in H63D homozygotes: are genetic modifiers the cause?

Authors:  P Aguilar-Martinez; M Bismuth; M C Picot; C Thelcide; G P Pageaux; F Blanc; P Blanc; J F Schved; D Larrey
Journal:  Gut       Date:  2001-06       Impact factor: 23.059

3.  Non-alcoholic fatty liver disease: is iron relevant?

Authors:  Julia O'Brien; Lawrie W Powell
Journal:  Hepatol Int       Date:  2011-08-12       Impact factor: 6.047

4.  Evaluation of MR imaging with T1 and T2* mapping for the determination of hepatic iron overload.

Authors:  B Henninger; C Kremser; S Rauch; R Eder; H Zoller; A Finkenstedt; H J Michaely; M Schocke
Journal:  Eur Radiol       Date:  2012-05-30       Impact factor: 5.315

5.  Different forms of iron accumulation in the liver on MRI.

Authors:  İlkay S İdilman; Deniz Akata; Mustafa Nasuh Özmen; Muşturay Karçaaltıncaba
Journal:  Diagn Interv Radiol       Date:  2016 Jan-Feb       Impact factor: 2.630

Review 6.  Dysregulation of iron and copper homeostasis in nonalcoholic fatty liver.

Authors:  Elmar Aigner; Günter Weiss; Christian Datz
Journal:  World J Hepatol       Date:  2015-02-27

7.  Abnormally high serum ferritin levels among professional road cyclists.

Authors:  H Zotter; N Robinson; M Zorzoli; L Schattenberg; M Saugy; P Mangin
Journal:  Br J Sports Med       Date:  2004-12       Impact factor: 13.800

8.  Fatty liver in H63D homozygotes with hyperferritinemia.

Authors:  Giada Sebastiani; Daniel F Wallace; Susan E Davies; Vasu Kulhalli; Ann P Walker; James S Dooley
Journal:  World J Gastroenterol       Date:  2006-03-21       Impact factor: 5.742

Review 9.  Interaction of iron, insulin resistance, and nonalcoholic steatohepatitis.

Authors:  Shivakumar Chitturi; Jacob George
Journal:  Curr Gastroenterol Rep       Date:  2003-02

10.  Hyperferritinemia in the Chinese and Asian community: a retrospective review of the University of British Columbia experience.

Authors:  Paul R Yenson; Eric M Yoshida; Charles H Li; Henry V Chung; Peter Wk Tsang
Journal:  Can J Gastroenterol       Date:  2008-01       Impact factor: 3.522

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.